Stock Fundamentals

Coromandel International: Sowing seeds for growth

Nalinakanthi V | Updated on March 13, 2018 Published on August 16, 2015




The company’s performance is set to improve as key concerns get addressed

The stock of the country’s leading phosphatic producer Coromandel International has fallen by almost 15 per cent in the last six months, due to weaker-than-expected performance. In the recent June quarter too, the company’s profit took a beating on three counts.

First, inadequate availability of key raw material phosphoric acid forced the company to produce other low grade complex fertilisers in place of di-ammonium phosphate (DAP).

Second, adverse revenue mix due to higher share of trading revenues — particularly DAP — led to a moderation in the company’s profitability. Third, Coromandel’s working capital borrowing witnessed a sharp rise in the June quarter due to delay in subsidy payment by the government. The consequent increase in interest outgo and forex premium (on raw material imports) ate into the company’s profit.

But these concerns have begun to abate.

Profits to improve

Coromandel has secured phosphoric acid supplies for the next two quarters. This should help the company resume DAP production. With a pick up in the demand for other grades of complex fertilisers, the company should be able to liquidate its channel inventory over the next two quarters.

Higher contribution from own manufactured fertilisers should provide a leg-up to Coromandel’s profitability in the coming quarters. The stock now trades at about 10 times its 2016-17 earnings, below its historical average of about 12 times. Investors with a two- to three-year horizon can consider buying the stock.

Coromandel has completed negotiations for buying phosphoric acid for the next two quarters. Availability of phosphoric acid from the company’s Tunisian joint venture initiative TIFERT should help it ramp up DAP production over the next two quarters. This should improve operating profit margin.

Also, the company has started receiving subsidy from the government, which was outstanding since April 2015. This should help Coromandel pare its working capital borrowing and ease the pressure on bottomline.

To reduce dependency on government subsidy, the company has been scaling up its non-subsidy businesses, such as agrochemicals and specialty chemicals. In the June quarter, the non-subsidy businesses accounted for 44 per cent of Coromandel’s consolidated operating profit, higher than the 40 per cent share two years back.

Scaling up presence

The performance of Sabero Organics, acquired by Coromandel in 2011, has improved steadily over the past few quarters.

The company is ramping up utilisation levels at its Sarigam plant (Gujarat) and also plans to increase capacity. In the June quarter, Coromandel’s overall agrochemicals business, which includes Sabero, faced demand issues in India and Latin America (Latam).

In the domestic market, unseasonal rabi rainfall played spoilsport. Sales in the Latam geography were hit due to a change in the product preference of customers and adverse weather conditions.

However, the company managed to scale up presence in its Asian and African markets — that largely made up for the slowdown in the domestic and Latam markets. Further, the company plans to strengthen its agrochemical brands, such as Mancozeb; this will improve realisations and support growth.

The profitability of Coromandel’s agrochemicals business should also benefit from the fall in gas prices. The company’s single super phosphate (SSP) business, which includes Liberty Phosphates acquired in 2013, has seen healthy growth.

Its market share in SSP has increased to 16 per cent from 12 per cent over the year. Coromandel’s specialty fertilisers business is also gathering pace. All these should help the company reduce dependency on subsidy as well as improve profitability. However, given the company’s high dependency on import of raw materials, further rupee weakness against the US dollar may hurt profitability.

Published on August 16, 2015

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.